Plasmablastic lymphoma presenting as a paravertebral mass in a patient with Crohn's disease after immunosuppressive therapy

Journal of Clinical Pathology

Volumn 60, Issue 1, 2007, Pages 80-81

  Redmond, M ^a   Quinn, J ^a   Murphy, P ^a   Patchett, S ^a   Leader, M ^a  

^a BEAUMONT HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID DERIVATIVE; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; MESALAZINE; VINCRISTINE;

ADULT; ANAMNESIS; ARTICLE; BIOPSY; CANCER CHEMOTHERAPY; CASE REPORT; CELL DIFFERENTIATION; CLINICAL FEATURE; CROHN DISEASE; DIET THERAPY; DISEASE EXACERBATION; ELEMENTAL DIET; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; LYMPHOMA; MALE; MORPHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMABLASTIC LYMPHOMA; PLASMACYTOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SKIN NODULE; VERTEBRA;

ADULT; ANTIBODIES, MONOCLONAL; CROHN DISEASE; GASTROINTESTINAL AGENTS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL, DIFFUSE; MALE; SPINAL NEOPLASMS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33846443943     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2006.037556     Document Type: Article

References (12)

1. Flaitz CM, Nichols CM, Walling DM, et al. Plasmablastic lymphoma: an HIV-associated entity with primary oral manifestations. Oral Oncol 2002;38:96-102.
2. Lin Y, Rodrigues GD, Turner JF, et al. Plasmablastic lymphoma of the lung: report of a unique case and review of the literature. Arch Pathol Lab Med 2001;125:282-5.
3. Nguyen DD, Loo BW, Tillman G, et al. Plasmablastic lymphoma presenting in a human immunodeficiency virus-negative patient: a case report. Ann Hematol 2003;82:521-5.
4. Pruneri G, Graziadei G, Ermellino L, et al. Plasmablastic lymphoma of the stomach. A case report. Haematologica 1998;83:87-9.
5. Robak T, Urbanska-Rys H, Strzelecka B, et al. Plasmablastic lymphoma in a patient with chronic lymphocytic leukaemia heavily pretreated with cladribine (2-CdA): an unusual variant of Richters syndrome. Eur J Haematol Suppl 2001;67:322-7.
6. Lin F, Zhanq K, Quiery A, et al. Plasmablastic lymphoma of the cervical lymph nodes in a numan immunodeficiency virus-negative patient: a case report and review of the literature. Arch Pathol Lab Med 2004;128:581-4.
7. Jordan LB. Lessells AM, Goodlad JR, et al. Plasmablastic lymphoma arising at a cutaneous site. Histopathology 2005;46:113.
8. Nicol I, Boye T, Carsuzaa F, et al. Post-transplant plasmablastic lymphoma of the skin. Br J Dermatol 2003;149:889.
9. Teruya-Feldstein J, Chiao E, Filipa A, et al. CD20-negative large-cell lymphoma with plasmablastic features: a clinically heterogeneous spectrum in both HIV-positive and -negative patients. Ann Oncol 2004;15:1673-9.
10. Chetty R, Hlatswayo N, Muc R, et al. Plasmablastic lymphoma in HIV+ patients: an expanding spectrum. Histopathology 2003;42:605-9.
11. Colomo L, Loong F, Rives S, et al. Diffuse B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities. Am J Surg Pathol 2004;28:736-47.
12. Bealy MW, Kumar S, Sorbara L, et al. A biophenotypic human herpesvirus 8-associated primary bowel lymphoma. Am J Surg Pathol 1999;23:992-4.